Where do new drugs fit into the treatment landscape of multiple myeloma
Myeloma 2017 day 2 highlights: MRD, targeted therapies and imaging advances
Gareth Morgan et al.
The benefits of lenalidomide and dexamethasone for multiple myeloma
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
Recently approved drugs for the treatment of multiple myeloma